annual shareholders equity:
$377.48M-$476.00K(-0.13%)Summary
- As of today (May 23, 2025), AUPH annual stockholders equity is $377.48 million, with the most recent change of -$476.00 thousand (-0.13%) on December 31, 2024.
- During the last 3 years, AUPH annual shareholders equity has fallen by -$101.61 million (-21.21%).
- AUPH annual shareholders equity is now -21.21% below its all-time high of $479.09 million, reached on December 31, 2021.
Performance
AUPH Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$350.19M-$27.29M(-7.23%)Summary
- As of today (May 23, 2025), AUPH quarterly stockholders equity is $350.19 million, with the most recent change of -$27.29 million (-7.23%) on March 31, 2025.
- Over the past year, AUPH quarterly shareholders equity has dropped by -$9.29 million (-2.58%).
- AUPH quarterly shareholders equity is now -26.91% below its all-time high of $479.09 million, reached on December 31, 2021.
Performance
AUPH quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
AUPH Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.1% | -2.6% |
| 3 y3 years | -21.2% | -21.9% |
| 5 y5 years | +26.4% | +33.0% |
AUPH Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -21.2% | at low | -21.9% | at low |
| 5 y | 5-year | -21.2% | +26.4% | -26.9% | +46.5% |
| alltime | all time | -21.2% | >+9999.0% | -26.9% | >+9999.0% |
AUPH Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $350.19M(-7.2%) |
| Dec 2024 | $377.48M(-0.1%) | $377.48M(-2.7%) |
| Sep 2024 | - | $388.00M(+6.4%) |
| Jun 2024 | - | $364.62M(+1.4%) |
| Mar 2024 | - | $359.48M(-4.9%) |
| Dec 2023 | $377.95M(-6.8%) | $377.95M(-3.6%) |
| Sep 2023 | - | $391.88M(-0.1%) |
| Jun 2023 | - | $392.29M(+0.5%) |
| Mar 2023 | - | $390.41M(-3.7%) |
| Dec 2022 | $405.44M(-15.4%) | $405.44M(-4.2%) |
| Sep 2022 | - | $423.43M(-0.1%) |
| Jun 2022 | - | $423.77M(-5.4%) |
| Mar 2022 | - | $448.12M(-6.5%) |
| Dec 2021 | $479.09M(+17.5%) | $479.09M(+60.7%) |
| Sep 2021 | - | $298.17M(-10.3%) |
| Jun 2021 | - | $332.26M(-10.3%) |
| Mar 2021 | - | $370.23M(-9.2%) |
| Dec 2020 | $407.75M(+36.6%) | $407.75M(+2.2%) |
| Sep 2020 | - | $398.84M(+66.9%) |
| Jun 2020 | - | $239.04M(-9.3%) |
| Mar 2020 | - | $263.41M(-11.8%) |
| Dec 2019 | $298.60M(+165.2%) | $298.60M(+141.3%) |
| Sep 2019 | - | $123.74M(-1.7%) |
| Jun 2019 | - | $125.87M(-9.7%) |
| Mar 2019 | - | $139.34M(+23.8%) |
| Dec 2018 | $112.58M(-32.1%) | $112.58M(-10.2%) |
| Sep 2018 | - | $125.34M(-11.8%) |
| Jun 2018 | - | $142.17M(-6.7%) |
| Mar 2018 | - | $152.45M(-8.0%) |
| Dec 2017 | $165.74M(+361.0%) | $165.74M(-1.1%) |
| Sep 2017 | - | $167.64M(-6.1%) |
| Jun 2017 | - | $178.47M(+3.4%) |
| Mar 2017 | - | $172.66M(+380.3%) |
| Dec 2016 | $35.95M(+80.1%) | $35.95M(+78.8%) |
| Sep 2016 | - | $20.10M(+2.9%) |
| Jun 2016 | - | $19.54M(+21.9%) |
| Mar 2016 | - | $16.02M(-19.7%) |
| Dec 2015 | $19.96M(-41.1%) | $19.96M(-15.2%) |
| Sep 2015 | - | $23.54M(-16.0%) |
| Jun 2015 | - | $28.01M(+1.6%) |
| Mar 2015 | - | $27.56M(-18.6%) |
| Dec 2014 | $33.87M(+154.4%) | $33.87M(-31.3%) |
| Sep 2014 | - | $49.32M(-3.4%) |
| Jun 2014 | - | $51.07M(-6.5%) |
| Mar 2014 | - | $54.62M(+310.3%) |
| Dec 2013 | $13.31M(-728.6%) | $13.31M(+8.8%) |
| Sep 2013 | - | $12.23M(-522.6%) |
| Jun 2013 | - | -$2.89M(-0.9%) |
| Mar 2013 | - | -$2.92M(+37.9%) |
| Dec 2012 | -$2.12M(-133.0%) | -$2.12M(-195.9%) |
| Sep 2012 | - | $2.21M(-41.5%) |
| Jun 2012 | - | $3.77M(-38.7%) |
| Mar 2012 | - | $6.16M(-4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $6.41M(+1.0%) | $6.41M(-48.6%) |
| Sep 2011 | - | $12.47M(+15.3%) |
| Jun 2011 | - | $10.82M(+83.1%) |
| Mar 2011 | - | $5.91M(-6.9%) |
| Dec 2010 | $6.35M(+32.0%) | $6.35M(-21.5%) |
| Sep 2010 | - | $8.09M(+54.7%) |
| Jun 2010 | - | $5.23M(-9.4%) |
| Mar 2010 | - | $5.77M(+20.0%) |
| Dec 2009 | $4.81M(-38.9%) | $4.81M(-20.9%) |
| Sep 2009 | - | $6.08M(-14.5%) |
| Jun 2009 | - | $7.11M(+64.5%) |
| Mar 2009 | - | $4.32M(-45.1%) |
| Dec 2008 | $7.87M(-72.3%) | $7.87M(-42.0%) |
| Sep 2008 | - | $13.58M(-23.4%) |
| Jun 2008 | - | $17.73M(-21.5%) |
| Mar 2008 | - | $22.59M(-20.5%) |
| Dec 2007 | $28.41M(+40.9%) | $28.41M(-22.7%) |
| Sep 2007 | - | $36.77M(-10.6%) |
| Jun 2007 | - | $41.15M(-11.4%) |
| Mar 2007 | - | $46.42M(+130.2%) |
| Dec 2006 | $20.17M(-52.4%) | $20.17M(-27.4%) |
| Sep 2006 | - | $27.79M(-18.4%) |
| Jun 2006 | - | $34.07M(-10.0%) |
| Mar 2006 | - | $37.87M(-10.6%) |
| Dec 2005 | $42.36M(-18.9%) | $42.36M(-18.0%) |
| Sep 2005 | - | $51.66M(+31.8%) |
| Jun 2005 | - | $39.19M(-14.7%) |
| Mar 2005 | - | $45.93M(-12.0%) |
| Dec 2004 | $52.20M(-23.8%) | $52.20M(-8.9%) |
| Sep 2004 | - | $57.33M(-6.1%) |
| Jun 2004 | - | $61.03M(-6.0%) |
| Mar 2004 | - | $64.96M(-5.2%) |
| Dec 2003 | $68.54M(+44.1%) | $68.54M(-4.7%) |
| Sep 2003 | - | $71.96M(+14.7%) |
| Jun 2003 | - | $62.76M(+34.5%) |
| Mar 2003 | - | $46.66M(-1.9%) |
| Dec 2002 | $47.56M(+34.8%) | $47.56M(-4.7%) |
| Sep 2002 | - | $49.91M(+0.6%) |
| Jun 2002 | - | $49.63M(+37.2%) |
| Mar 2002 | - | $36.17M(+36.2%) |
| Dec 2001 | $35.28M(+176.5%) | - |
| Aug 2001 | - | $26.56M(+165.4%) |
| May 2001 | - | $10.01M(-11.7%) |
| Feb 2001 | - | $11.33M(-11.2%) |
| Nov 2000 | $12.76M(+299.7%) | $12.76M(+12.5%) |
| Aug 2000 | - | $11.35M(-1.7%) |
| May 2000 | - | $11.55M(+184.0%) |
| Feb 2000 | - | $4.07M(+27.4%) |
| Nov 1999 | $3.19M(-477.1%) | $3.19M(+267.0%) |
| Aug 1999 | - | $869.80K(+6.9%) |
| May 1999 | - | $813.80K(-5.6%) |
| Feb 1999 | - | $861.80K |
| Nov 1998 | -$846.40K | - |
FAQ
- What is Aurinia Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals annual shareholders equity year-on-year change?
- What is Aurinia Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Aurinia Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of AUPH is $377.48M
What is the all time high annual shareholders equity for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high annual stockholders equity is $479.09M
What is Aurinia Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, AUPH annual stockholders equity has changed by -$476.00K (-0.13%)
What is Aurinia Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of AUPH is $350.19M
What is the all time high quarterly shareholders equity for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high quarterly stockholders equity is $479.09M
What is Aurinia Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, AUPH quarterly stockholders equity has changed by -$9.29M (-2.58%)